NCT05619367 2025-12-23A Compassionate Use (CU) Program of OdronextamabRegeneron PharmaceuticalsAvailable
NCT05776160 2025-12-01Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene CiloleucelGilead SciencesAvailable